Partitioning of cancer therapeutics in nuclear condensates

© 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works The nucleus contains diverse phase-separated condensates that compartmentalize and concentrate biomolecules with distinct physicochemical prope...

Full description

Bibliographic Details
Main Authors: Klein, Isaac A., Boija, Ann, Afeyan, Lena K., Hawken, Susana Wilson, Fan, Mengyang, Dall'Agnese, Alessandra, Oksuz, Ozgur, Henninger, Jonathan E., Shrinivas, Krishna, Sabari, Benjamin R., Sagi, Ido, Clark, Victoria E., Platt, Jesse M., Kar, Mrityunjoy, McCall, Patrick M., Zamudio, Alicia V., Manteiga, John C., Coffey, Eliot L., Li, Charles H., Hannett, Nancy M., Guo, Yang Eric, Decker, Tim-Michael, Lee, Tong Ihn, Zhang, Tinghu, Weng, Jing-Ke, Taatjes, Dylan J., Chakraborty, Arup, Sharp, Phillip A., Chang, Young Tae, Hyman, Anthony A., Gray, Nathanael S., Young, Richard A.
Other Authors: Whitehead Institute for Biomedical Research
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2022
Online Access:https://hdl.handle.net/1721.1/135217.2
_version_ 1810977045412315136
author Klein, Isaac A.
Boija, Ann
Afeyan, Lena K.
Hawken, Susana Wilson
Fan, Mengyang
Dall'Agnese, Alessandra
Oksuz, Ozgur
Henninger, Jonathan E.
Shrinivas, Krishna
Sabari, Benjamin R.
Sagi, Ido
Clark, Victoria E.
Platt, Jesse M.
Kar, Mrityunjoy
McCall, Patrick M.
Zamudio, Alicia V.
Manteiga, John C.
Coffey, Eliot L.
Li, Charles H.
Hannett, Nancy M.
Guo, Yang Eric
Decker, Tim-Michael
Lee, Tong Ihn
Zhang, Tinghu
Weng, Jing-Ke
Taatjes, Dylan J.
Chakraborty, Arup
Sharp, Phillip A.
Chang, Young Tae
Hyman, Anthony A.
Gray, Nathanael S.
Young, Richard A.
author2 Whitehead Institute for Biomedical Research
author_facet Whitehead Institute for Biomedical Research
Klein, Isaac A.
Boija, Ann
Afeyan, Lena K.
Hawken, Susana Wilson
Fan, Mengyang
Dall'Agnese, Alessandra
Oksuz, Ozgur
Henninger, Jonathan E.
Shrinivas, Krishna
Sabari, Benjamin R.
Sagi, Ido
Clark, Victoria E.
Platt, Jesse M.
Kar, Mrityunjoy
McCall, Patrick M.
Zamudio, Alicia V.
Manteiga, John C.
Coffey, Eliot L.
Li, Charles H.
Hannett, Nancy M.
Guo, Yang Eric
Decker, Tim-Michael
Lee, Tong Ihn
Zhang, Tinghu
Weng, Jing-Ke
Taatjes, Dylan J.
Chakraborty, Arup
Sharp, Phillip A.
Chang, Young Tae
Hyman, Anthony A.
Gray, Nathanael S.
Young, Richard A.
author_sort Klein, Isaac A.
collection MIT
description © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works The nucleus contains diverse phase-separated condensates that compartmentalize and concentrate biomolecules with distinct physicochemical properties. Here, we investigated whether condensates concentrate small-molecule cancer therapeutics such that their pharmacodynamic properties are altered. We found that antineoplastic drugs become concentrated in specific protein condensates in vitro and that this occurs through physicochemical properties independent of the drug target. This behavior was also observed in tumor cells, where drug partitioning influenced drug activity. Altering the properties of the condensate was found to affect the concentration and activity of drugs. These results suggest that selective partitioning and concentration of small molecules within condensates contributes to drug pharmacodynamics and that further understanding of this phenomenon may facilitate advances in disease therapy.
first_indexed 2024-09-23T09:04:55Z
format Article
id mit-1721.1/135217.2
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T09:04:55Z
publishDate 2022
publisher American Association for the Advancement of Science (AAAS)
record_format dspace
spelling mit-1721.1/135217.22024-05-21T19:07:32Z Partitioning of cancer therapeutics in nuclear condensates Klein, Isaac A. Boija, Ann Afeyan, Lena K. Hawken, Susana Wilson Fan, Mengyang Dall'Agnese, Alessandra Oksuz, Ozgur Henninger, Jonathan E. Shrinivas, Krishna Sabari, Benjamin R. Sagi, Ido Clark, Victoria E. Platt, Jesse M. Kar, Mrityunjoy McCall, Patrick M. Zamudio, Alicia V. Manteiga, John C. Coffey, Eliot L. Li, Charles H. Hannett, Nancy M. Guo, Yang Eric Decker, Tim-Michael Lee, Tong Ihn Zhang, Tinghu Weng, Jing-Ke Taatjes, Dylan J. Chakraborty, Arup Sharp, Phillip A. Chang, Young Tae Hyman, Anthony A. Gray, Nathanael S. Young, Richard A. Whitehead Institute for Biomedical Research Massachusetts Institute of Technology. Department of Physics Massachusetts Institute of Technology. Department of Chemical Engineering Massachusetts Institute of Technology. Institute for Medical Engineering & Science Massachusetts Institute of Technology. Department of Chemistry Massachusetts Institute of Technology. Department of Biological Engineering Koch Institute for Integrative Cancer Research at MIT © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works The nucleus contains diverse phase-separated condensates that compartmentalize and concentrate biomolecules with distinct physicochemical properties. Here, we investigated whether condensates concentrate small-molecule cancer therapeutics such that their pharmacodynamic properties are altered. We found that antineoplastic drugs become concentrated in specific protein condensates in vitro and that this occurs through physicochemical properties independent of the drug target. This behavior was also observed in tumor cells, where drug partitioning influenced drug activity. Altering the properties of the condensate was found to affect the concentration and activity of drugs. These results suggest that selective partitioning and concentration of small molecules within condensates contributes to drug pharmacodynamics and that further understanding of this phenomenon may facilitate advances in disease therapy. 2022-02-07T15:54:22Z 2021-10-27T20:22:31Z 2022-02-07T15:54:22Z 2020-06 2019-09 2021-06-08T17:52:58Z Article http://purl.org/eprint/type/JournalArticle 0036-8075 1095-9203 https://hdl.handle.net/1721.1/135217.2 en http://dx.doi.org/10.1126/science.aaz4427 Science Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/octet-stream American Association for the Advancement of Science (AAAS) PMC
spellingShingle Klein, Isaac A.
Boija, Ann
Afeyan, Lena K.
Hawken, Susana Wilson
Fan, Mengyang
Dall'Agnese, Alessandra
Oksuz, Ozgur
Henninger, Jonathan E.
Shrinivas, Krishna
Sabari, Benjamin R.
Sagi, Ido
Clark, Victoria E.
Platt, Jesse M.
Kar, Mrityunjoy
McCall, Patrick M.
Zamudio, Alicia V.
Manteiga, John C.
Coffey, Eliot L.
Li, Charles H.
Hannett, Nancy M.
Guo, Yang Eric
Decker, Tim-Michael
Lee, Tong Ihn
Zhang, Tinghu
Weng, Jing-Ke
Taatjes, Dylan J.
Chakraborty, Arup
Sharp, Phillip A.
Chang, Young Tae
Hyman, Anthony A.
Gray, Nathanael S.
Young, Richard A.
Partitioning of cancer therapeutics in nuclear condensates
title Partitioning of cancer therapeutics in nuclear condensates
title_full Partitioning of cancer therapeutics in nuclear condensates
title_fullStr Partitioning of cancer therapeutics in nuclear condensates
title_full_unstemmed Partitioning of cancer therapeutics in nuclear condensates
title_short Partitioning of cancer therapeutics in nuclear condensates
title_sort partitioning of cancer therapeutics in nuclear condensates
url https://hdl.handle.net/1721.1/135217.2
work_keys_str_mv AT kleinisaaca partitioningofcancertherapeuticsinnuclearcondensates
AT boijaann partitioningofcancertherapeuticsinnuclearcondensates
AT afeyanlenak partitioningofcancertherapeuticsinnuclearcondensates
AT hawkensusanawilson partitioningofcancertherapeuticsinnuclearcondensates
AT fanmengyang partitioningofcancertherapeuticsinnuclearcondensates
AT dallagnesealessandra partitioningofcancertherapeuticsinnuclearcondensates
AT oksuzozgur partitioningofcancertherapeuticsinnuclearcondensates
AT henningerjonathane partitioningofcancertherapeuticsinnuclearcondensates
AT shrinivaskrishna partitioningofcancertherapeuticsinnuclearcondensates
AT sabaribenjaminr partitioningofcancertherapeuticsinnuclearcondensates
AT sagiido partitioningofcancertherapeuticsinnuclearcondensates
AT clarkvictoriae partitioningofcancertherapeuticsinnuclearcondensates
AT plattjessem partitioningofcancertherapeuticsinnuclearcondensates
AT karmrityunjoy partitioningofcancertherapeuticsinnuclearcondensates
AT mccallpatrickm partitioningofcancertherapeuticsinnuclearcondensates
AT zamudioaliciav partitioningofcancertherapeuticsinnuclearcondensates
AT manteigajohnc partitioningofcancertherapeuticsinnuclearcondensates
AT coffeyeliotl partitioningofcancertherapeuticsinnuclearcondensates
AT licharlesh partitioningofcancertherapeuticsinnuclearcondensates
AT hannettnancym partitioningofcancertherapeuticsinnuclearcondensates
AT guoyangeric partitioningofcancertherapeuticsinnuclearcondensates
AT deckertimmichael partitioningofcancertherapeuticsinnuclearcondensates
AT leetongihn partitioningofcancertherapeuticsinnuclearcondensates
AT zhangtinghu partitioningofcancertherapeuticsinnuclearcondensates
AT wengjingke partitioningofcancertherapeuticsinnuclearcondensates
AT taatjesdylanj partitioningofcancertherapeuticsinnuclearcondensates
AT chakrabortyarup partitioningofcancertherapeuticsinnuclearcondensates
AT sharpphillipa partitioningofcancertherapeuticsinnuclearcondensates
AT changyoungtae partitioningofcancertherapeuticsinnuclearcondensates
AT hymananthonya partitioningofcancertherapeuticsinnuclearcondensates
AT graynathanaels partitioningofcancertherapeuticsinnuclearcondensates
AT youngricharda partitioningofcancertherapeuticsinnuclearcondensates